William Gillanders, MD

Surgeon

William Gillanders

Appointment Options

Whether you’re seeking a new patient appointment or exploring treatment options and looking for a second opinion, our Siteman care coordinators are ready to assist you.

My Locations

Gary C. Werths Building at Siteman Cancer Center

Gary C. Werths Building at Siteman Cancer Center

On WashU Medicine Campus
4500 Forest Park Avenue, Saint Louis, MO 63108

Expertise & Training

Video thumbnail for William E. Gillanders, MD

Watch video on YouTube

William E. Gillanders, MD

4 mins

Washington University surgeon William Gillanders, MD, discusses what thyroid and breast cancer patients can expect from their extended care team at Siteman Cancer Center.

Clinical Expertise

Primary Academic Title

Professor and Vice-Chair, Department of Surgery, Division of General Surgery, Section of Surgical Oncology, WashU Medicine

Board Certification

  • 2000: American Board of Surgery, General Surgery

Training

  • 1991 - 1993: Resident, General Surgery, WashU Medicine, St. Louis, MO
  • 1993 - 1996: ResearchFellow, Immunology, WashU Medicine, St. Louis, MO
  • 1996 - 1999: Resident and Chief Resident, General Surgery, WashU Medicine, St. Louis, MO

Education

  • 1991: MD, Duke University, Durham, NC
  • 2005: MSCR, Medical University of South Carolina, Charleston, SC

Research & Selected Publications

Research Interest

Translational research in cancer immunotherapy; neoantigen cancer vaccine development

Research Publications

Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial
Authors:

Garfinkle EAR, Perales-Linares R, Gimple RC, one or more additional authors omitted Gillanders WE, one or more additional authors omitted Johanns TM

Journal & Year:

Nat Cancer | 2026

Neoadjuvant Endocrine Treatment plus Mammaglobin-A DNA Vaccine Induces Antitumor Immune Responses in the Primary Tumor and Peripheral Blood of Patients with Breast Cancer: Insights…
Authors:

Mishra R, Ademuyiwa F, Yang Y, one or more additional authors omitted Gillanders WE

Journal & Year:

Cancer Immunol Res | 2026

Long-Acting Recombinant IL-7 (rhIL-7-hyFc) Enhances the Primary and Memory Neoantigen-Specific Immune Response to Breast Cancer Personalized Cancer Vaccines
Authors:

Chen M, Kane T, Chen I, one or more additional authors omitted Gillanders WE

Journal & Year:

Cancers (Basel) | 2025

Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients
Authors:

Zhang X, Goedegebuure SP, Chen MY, one or more additional authors omitted Gillanders WE

Journal & Year:

Genome Med | 2024

pVACview: an interactive visualization tool for efficient neoantigen prioritization and selection
Authors:

Xia H, Hoang MH, Schmidt E, one or more additional authors omitted Gillanders WE, one or more additional authors omitted Griffith M

Journal & Year:

Genome Med | 2024

Differential chromatin accessibility and transcriptional dynamics define breast cancer subtypes and their lineages
Authors:

Iglesia MD, Jayasinghe RG, Chen S, one or more additional authors omitted Gillanders WE, Ding L

Journal & Year:

Nat Cancer | 2024

Tumour evolution and microenvironment interactions in 2D and 3D space
Authors:

Mo CK, Liu J, Chen S, one or more additional authors omitted Gillanders WE, one or more additional authors omitted Ding L

Journal & Year:

Nature | 2024

Cost-Effectiveness of Parathyroid Cryopreservation and Autotransplantation
Authors:

Frye CC, Sullivan J, Sanka SA, one or more additional authors omitted Gillanders W, one or more additional authors omitted Pandian TK

Journal & Year:

JAMA Surg | 2024